News > Despite UK nod, India in no hurry to approve Oxford vaccine, asks for more data

Despite UK nod, India in no hurry to approve Oxford vaccine, asks for more data

Central Drugs Standard Control Organisation's Subject Expert Committee (SEC) held a meeting on Wednesday to decide on approving a vaccine against Covid-19 for use in India.

After the meeting, the SEC said more data was needed for the Oxford-AstraZeneca 'Covishield' vaccine and Bharat Biotech's 'Covaxin' to be granted approval for emergency use. The SEC will meet again on Friday, January 1, to discuss Emergency Use Authorisation (EUA) to the Covid-19 vaccines.